A-Z Drug Index & Medical Treatments
Welcome to the Pharma Guide General Medicine Index, a comprehensive clinical database designed for healthcare professionals and patients across the MENA region. This central directory, curated under the rigorous oversight of Dr. Ahmad Baker, organizes thousands of medications by therapeutic class, body system, and active ingredient. Our goal is to provide a transparent, evidence-based look at the pharmaceutical landscape—from common over-the-counter (OTC) remedies to specialized prescription-only treatments. Each entry includes localized insights into drug availability, standard dosage protocols, and safety warnings. Whether you are researching respiratory treatments or cardiovascular medications, our index is designed to bridge the gap between complex pharmacology and practical health management.
Professional Guidance: This index is for informational purposes only. Prescription medications should never be started or discontinued without a formal consultation and valid prescription from a licensed medical practitioner.
Adol (paracetamol) provides rapid relief for pain and fever. Adult max is 4,000 mg/day with 4-hour spacing. Avoid combining with other paracetamol products to prevent liver toxicity.
Ecinq 30 mg (ulipristal acetate) is a selective progesterone receptor modulator indicated for emergency post-coital contraception within 120 hours of unprotected intercourse. This comprehensive clinical monograph reviews its superiority over levonorgestrel during the LH surge, the critical 5-day waiting window before starting regular hormonal contraceptives, and weight-based efficacy considerations.
Early pregnancy loss is predominantly caused by spontaneous chromosomal aneuploidies rather than maternal activities, stress, or minor physical exertion. This clinical guide explains the biological mechanisms of first-trimester miscarriage, debunks common myths fueling maternal self-blame, details evidence-based medical and surgical management protocols, and highlights the reassuring >85% success rate for future full-term pregnancies.
Retatrutide (LY3437943) is an investigational triple-hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors, producing up to 24.2% body weight loss in Phase 2 clinical trials. This clinical monograph examines the molecular pharmacodynamics, weekly reconstitution and dosing titration protocols, cardiac and pancreatitis alerts, and the safety risks surrounding grey-market research peptide formulations.
Darzalex SC 1800 mg is a fixed-dose subcutaneous formulation of daratumumab with recombinant hyaluronidase, enabling 3-to-5-minute administration for multiple myeloma and AL amyloidosis. This comprehensive guide covers the anti-CD38 mechanism, dosing schedule, blood bank cross-matching interference, adverse reactions, therapeutic alternatives, and regional pricing across MENA markets.
Tremfya 100 mg is a first-in-class selective IL-23 inhibitor containing guselkumab, administered via a convenient pre-filled auto-injector pen every 8 weeks for moderate-to-severe plaque psoriasis, psoriatic arthritis, and ulcerative colitis. This comprehensive guide covers molecular pharmacology, step-by-step injection technique, adverse reactions, therapeutic alternatives, and regional pricing across MENA markets.
Mantroxate 250 mg is a CYP17 inhibitor containing abiraterone acetate, indicated for metastatic castration-resistant and hormone-sensitive prostate cancer. This comprehensive guide covers weight-based dosing, the critical fasting requirement, prednisone co-administration rationale, adverse effects, and therapeutic alternatives.
Stelara 130 mg IV is a weight-based intravenous biologic induction therapy for adults with moderate-to-severe Crohn’s disease and ulcerative colitis. This comprehensive guide covers dosing calculations, aseptic preparation protocols, adverse reactions, and the transition to subcutaneous maintenance therapy.
Misoprostol failure affects 10-15% of users in Egypt and MENA. This guide explains signs of failure, common reasons, success rates by gestational age, and evidence-based next steps including repeat dosing per WHO guidelines.
This article explains whether Misotac can be used with a previous cesarean scar. While the risk of uterine rupture is low in early pregnancy with one low-transverse scar, it is not zero. Multiple scars, vertical incisions, or recent cesareans require extra caution. Medical consultation is essential before use.